Drug Shortage Report for ZELDOX

Last updated on 2023-01-17 History
Report ID 173314
Drug Identification Number 02298619
Brand name ZELDOX
Common or Proper name ZELDOX
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) ZIPRASIDONE
Strength(s) 60MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 60
ATC code N05AE
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-23
Estimated end date 2022-12-27
Actual end date 2023-01-09
Shortage status Resolved
Updated date 2023-01-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-02 English Compare
v2 2022-11-02 English Compare
v3 2022-11-02 French Compare
v4 2022-11-24 English Compare
v5 2023-01-17 English Compare
v6 2023-01-17 French Compare

Showing 1 to 6 of 6